Novartis commits US$ 250 million to the fight against NTDs and malaria
This includes USD 100 million to advance R&D of its neglected tropical disease program, focusing on novel drug candidates for four diseases.
This includes USD 100 million to advance R&D of its neglected tropical disease program, focusing on novel drug candidates for four diseases.
It´s the first trial to demonstrate the benefits of dual pathway inhibition
Becomes first Japanese logistics company to collaborate with EMBALL’ISO, which has a proven track record in vaccine transport
Intended for potential treatment of ER+/HER2- advanced or metastatic breast cancer patients
This is the first Agilent lab to receive the My Green Lab Certification and plans are under way to certify additional labs.
Atik Cameras launches ChemiMOS; A 9MP CMOS camera for scientific applications
The company is now introducing the product into the India pharmaceutical market.
Agreement to co-develop artificial intelligence (AI) technology for the application in peptide drug design
The ground floor of the formulation development laboratory is focused on solid orals, the first floor on injections, and the second floor houses the analytical lab
This investment will facilitate a Cipla entity's strategic participation in the Poe diagnostics and AMR space through the design, development, and manufacturing of microfluidics-based technologies
Subscribe To Our Newsletter & Stay Updated